These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36825709)

  • 1. Stem Cells and Tumor-Killing Virus to Target Brain Tumor: In Pursuit to Bring a Potential Delivery Vehicle for the Central Nervous System Tumors.
    E VB; Ranganath Pai KS
    Curr Drug Deliv; 2024; 21(1):2-15. PubMed ID: 36825709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune System, Friend or Foe of Oncolytic Virotherapy?
    Filley AC; Dey M
    Front Oncol; 2017; 7():106. PubMed ID: 28589085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic virotherapy evolved into the fourth generation as tumor immunotherapy.
    Wang X; Shen Y; Wan X; Hu X; Cai WQ; Wu Z; Xin Q; Liu X; Gui J; Xin HY; Xin HW
    J Transl Med; 2023 Jul; 21(1):500. PubMed ID: 37491263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the potential of oncolytic viruses for cancer treatment via MSC delivery.
    Ghaleh HEG; Vakilzadeh G; Zahiri A; Farzanehpour M
    Cell Commun Signal; 2023 Sep; 21(1):228. PubMed ID: 37667271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic Virotherapy in Solid Tumors: The Challenges and Achievements.
    Jin KT; Du WL; Liu YY; Lan HR; Si JX; Mou XZ
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33546172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cell carriers enhance anti-tumor efficacy of oncolytic virotherapy.
    Wang X; Zhao X; He Z
    Oncol Lett; 2021 Apr; 21(4):238. PubMed ID: 33664802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic viruses: challenges and considerations in an evolving clinical landscape.
    Lauer UM; Beil J
    Future Oncol; 2022 Jul; ():. PubMed ID: 35818970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in targeting cancer stem cells using oncolytic viruses.
    Zhang YN; Wang SB; Song SS; Hu PY; Zhou YC; Mou YP; Mou XZ
    Biotechnol Lett; 2020 Jun; 42(6):865-874. PubMed ID: 32166558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas.
    Zeng J; Li X; Sander M; Zhang H; Yan G; Lin Y
    Front Immunol; 2021; 12():721830. PubMed ID: 34675919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cell-released oncolytic virus: an innovative strategy for cancer treatment.
    Ghasemi Darestani N; Gilmanova AI; Al-Gazally ME; Zekiy AO; Ansari MJ; Zabibah RS; Jawad MA; Al-Shalah SAJ; Rizaev JA; Alnassar YS; Mohammed NM; Mustafa YF; Darvishi M; Akhavan-Sigari R
    Cell Commun Signal; 2023 Feb; 21(1):43. PubMed ID: 36829187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. History of how viruses can fight cancer: From the miraculous healings to the approval of oncolytic viruses.
    Bifulco M; Di Zazzo E; Napolitano F; Malfitano AM; Portella G
    Biochimie; 2023 Mar; 206():89-92. PubMed ID: 36273765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic ImmunoViroTherapy: A long history of crosstalk between viruses and immune system for cancer treatment.
    Feola S; Russo S; Ylösmäki E; Cerullo V
    Pharmacol Ther; 2022 Aug; 236():108103. PubMed ID: 34954301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Advances and Future Directions of Oncolytic Virotherapy for Head and Neck Cancer.
    Wang Z; Sun P; Li Z; Xiao S
    Cancers (Basel); 2023 Nov; 15(21):. PubMed ID: 37958464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic Virotherapy in Glioma Tumors.
    Rius-Rocabert S; García-Romero N; García A; Ayuso-Sacido A; Nistal-Villan E
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virotherapy as a Potential Therapeutic Approach for the Treatment of Aggressive Thyroid Cancer.
    Malfitano AM; Somma SD; Prevete N; Portella G
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31636245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncolytic Viral Therapy and the Immune System: A Double-Edged Sword Against Cancer.
    Marelli G; Howells A; Lemoine NR; Wang Y
    Front Immunol; 2018; 9():866. PubMed ID: 29755464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncolytic Viruses as a Platform for the Treatment of Malignant Brain Tumors.
    Sostoa J; Dutoit V; Migliorini D
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunovirotherapy: The role of antibody based therapeutics combination with oncolytic viruses.
    Jafari M; Kadkhodazadeh M; Shapourabadi MB; Goradel NH; Shokrgozar MA; Arashkia A; Abdoli S; Sharifzadeh Z
    Front Immunol; 2022; 13():1012806. PubMed ID: 36311790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncolytic virotherapy as promising immunotherapy against cancer: mechanisms of resistance to oncolytic viruses.
    Goradel NH; Alizadeh A; Hosseinzadeh S; Taghipour M; Ghesmati Z; Arashkia A; Negahdari B
    Future Oncol; 2022 Jan; 18(2):245-259. PubMed ID: 34821517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic viruses and their application to cancer immunotherapy.
    Chiocca EA; Rabkin SD
    Cancer Immunol Res; 2014 Apr; 2(4):295-300. PubMed ID: 24764576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.